After the immunizing infection, the key experimental immunized-challenged group was rested for 4 weeks to enable the mucosa to recover, before being challenged with a low-dose secondary infection. Our hypothesis is that challenged animals should respond with a considerably more vigorous intestinal inflammatory response than that evident during primary exposure, and to enable this

to be quantified accurately against baseline values of each of the parameters that we measured, we included four carefully chosen control groups. The strain of A. ceylanicum used was that maintained at the University of Nottingham since 1984, originally acquired from Dr. Rajasekariah of Hindustan CIBA-Geigy Ltd., Bombay, India. It is believed to be of dog origin. The methods employed for maintenance of the parasite, for worm recovery and faecal egg counts have all been described previously in full (16,19). Worms were Ruxolitinib purchase removed from infected animals by treatment with ivermectin (‘Ivomec super’ MSD AGVET, Division of Merk Sharp and Dohme Limited, Holland). A stock concentration of 200 μg/mL drug was made by a 1 in 50 dilution using distilled water and this was used to treat at 200 μg/kg body weight. The Golden hamsters (DSN strain) used in this study were originally obtained from Harlan Olac in 1983 and since then maintained

in the animal house of the School of Biology as a closed colony. Only female hamsters were used

in this experiment. Animals were kept under conventional animal house conditions. Pelleted food and tap water were supplied selleck compound ad libitum. Cages were cleaned twice a week to prevent re-infection. Animals were first weighed 1 or 2 weeks before infection and thereafter twice a week until the completion of each experiment. As the colony was maintained under conventional animal house conditions, the animals were exposed to various micro-organisms present in the environment. To prepare hamsters for infection and reduce other competing intestinal micro-organisms, all animals were pre-treated for 1 week with Emtryl (May & Baker, Dimetridazole at a concentration of 1 g/L in drinking water), then for another week with Terramycin (Pfizer, oxytetracycline hydrochloride, 3 g/L in drinking oxyclozanide water) and were returned to normal drinking water for 1 week prior to infection. Animals were used at approximately 8–12 weeks of age. The methods used to measure the height of villi, the depth of the Crypts of Lieberkühn and mitotic activity were described comprehensively by Alkazmi et al. (20). Methods for assessing the mast cell, goblet cell, eosinophil and Paneth cell responses were reported earlier in full (18). In all the histological observations reported here, we counted cells/mm2 of mucosal tissue on appropriately stained sections, using the Weible 2 graticule as described by Kermanizadeh et al. (29).

2A). The following Selleckchem Everolimus day, the mice were immunized with their cognate peptide in CFA, and the numbers and activation status of transferred Teff cells were analyzed at various time points. As our studies in the EAE model demonstrated that fewer Teff cells were present in the target organ, we hypothesized that, in the presence of Treg cells, a decrease in Teff-cell proliferation would be observed. Surprisingly, Treg cells had no effect on Teff cells proliferation as measured by CFSE dilution and a two-fold increase in the percentage

and absolute number of Teff cells present in the draining LN was observed (Fig. 2B and D; Supporting Information Fig. S1A). Further analysis of the transferred T cells demonstrated that there was no difference in the percentage of cells differentiating into either Th1 or Th17 lineages, nor were there differences in the level of expression of the activation marker CD44 (Fig. 2C). As it remained possible that potential suppressive effects of Treg cell were blocked by the use of CFA as an adjuvant, we also immunized the mice with peptide-pulsed splenic DCs. The results were identical to those observed in

HTS assay the presence of CFA. Teff-cell proliferation was not blocked, and there was a greater than two-fold increase in the total number of the Teff cells in the spleen in the presence of Treg cells (Fig. 2D). Although the experiments in Fig. 2D were performed with CD4+CD25− T cells

from 2D2 mice that might contain a small number of CD25−Foxp3+ T cells, identical results were observed when Foxp3 Teff cells were purified from TCR-Tg mice on a RAG−/− background (Supporting Information Figs. S1A and S1B). Similar results were observed when we immunized the mice with pigeon cytochrome C (PCC) protein i.v. or transferred cytochrome-specific T cells to mice that transgenically expressed PCC (Supporting EGFR antibody inhibitor Information Fig. S2). Overall, these studies demonstrate the effects of polyclonal Treg cell under immunization strategies ranging from highly immunogenic (CFA) to tolerogenic (i.v. antigen or endogenous expression of antigen) all resulted in an amplification of the total number of Teff cells at the site of immunization. The protocol used in the previous experiments had the disadvantage of only being able to track one cell population at a time. We were therefore limited in our ability to track the relative dynamics of Teff cells and Treg cells at the same time. We addressed this issue by cotransferring CFSE-labeled CD45.2+Thy1.1− 2D2 TCR-Tg (specific for MOG35–55) Teff cells in the presence or absence of CFSE-labeled CD45.2+Thy1.1+ Treg cells into CD45.1+ recipients at a Teff cells to Treg cells ratio of 1:4. The ratio of Teff cells to Treg cells was chosen on the basis of previous experiments that demonstrated that the engraftment efficiency of Treg cells is far lower than that of Teff cells.

To avoid these technical limitations and directly determine whether CR3 and or CR4 are critical for the development and progression of ECM, we used mice deficient in these receptors. We compared susceptibility and clinical severity of CR3−/− (23), CR4−/− (24) and wild-type mice in Plasmodium berghei ANKA-induced ECM as previously LEE011 molecular weight described (25). All mice used in this

study were on the C57BL/6 background. For these studies, P. berghei ANKA was maintained by passage in BALB/c mice (26). ECM was induced by injecting mice i.p. with 5 × 105 PbA-infected RBCs. Peripheral parasitemia was monitored on day 6 postinfection by Giemsa-stained, thin-blood smears. Mice were monitored twice daily for clinical signs of neurologic disease using the following scoring scale: 0, asymptomatic; 1, symptomatic (ruffled fur); 2, mild disease (slow righting); 3, moderate disease (difficulty righting); 4, severe disease (ataxia, seizures, coma); 5, https://www.selleckchem.com/products/bmn-673.html dead. Mice observed having seizures were given a score of 4 regardless of other clinical signs of disease. Moribund animals were scored 4·5 and humanely sacrificed. Mice were classified as having ECM

if they displayed these symptoms between days 6 and 9 post-infection, had positive thin-blood smears and, had a corresponding drop in external body temperature or succumbed to infection. We found that CR3−/− and CR4−/− mice did not survive significantly longer than wild-type mice (P > 0·05, Log-rank test; Figure 1a,d) and that all three groups of mice succumbed to infection at the same rate. Disease severity in CR3−/− and CR4−/− mice was identical compared with wild-type mice and corresponded well to survival (Figure 1b,e). Interestingly, peripheral parasitemia was significantly elevated in CR3−/− (P = 0·0028, unpaired Student’s t-test), but not in CR4−/− mice compared with wild-type mice (Figure 1c,f). The latter results suggest a minor role for CR3 in parasite clearance, but not in survival or disease severity. The absence of an altered

disease phenotype in CR3−/− and CR4−/− mice raised questions regarding the role of other β2-integrin adhesion molecules in ECM. Previous studies have reported triclocarban minimal differences in the course of ECM through day 10 in CD11d−/− (αDβ2) mice (27) not unlike what we report here for CR3 and CR4. In contrast, LFA-1 (CD11a, (αLβ2), also a member of the β2-integrin family, is thought to play a key role in the development of ECM based on studies demonstrating significant protection from the development of ECM on treatment with anti-LFA-1 antibodies (21,22,28). To our knowledge, no one has directly assessed the role of LFA-1 in ECM using LFA-1−/− mice to verify these reports. Therefore, we performed ECM using LFA-1−/− mice (29).

The brain (1360 g after fixation) and spinal cord had a normal external appearance. In sections, the cerebrum, cerebellum, midbrain and medulla oblongata showed no abnormality. In the sections of the left pontine base, a punctate hemorrhage up to a diameter of 1 mm was noted. Neither ventricular dilatation, discoloration of the cerebellar dentate nuclei, nor atrophy of the mesencephalic tegmentum or superior cerebellar peduncles was found. Microscopically, the loss of Betz KU-60019 cell line cells in the motor cortex was moderate; and that of cells in the hypoglossal nuclei, cervical and lumbar anterior horns (AHs), and Clarke’s nuclei were obvious. Onufrowicz nuclei were well preserved. Bilateral tract degeneration was moderate in the spinocerebellar

tracts, and mild in the pyramidal tract, but nonexistent in the posterior column (Fig. 1A). In HE-stained sections, hyaline CIs, which were large, irregularly shaped, pale and intracytoplasmic inclusions, were observed in some of the remaining Betz cells (Fig. 1B), motor neurons in the hypoglossal nuclei, and AH cells in the cervical and lumbar spinal cord (Fig. 1D). In the cervical and lumbar AHs, some spheroids were observed. LBHIs, which had an eosinophilic core surrounded by a pale halo, were rarely observed in the hypoglossal nuclei or cervical or lumbar AHs (Fig. 1H). No Bunina bodies were seen. Incidental venous angioma and mild ferruginations were observed in the left pontine base. Immunohistochemical examination of the CIs showed them to be strongly positive for p-NFP (Fig. 1C,E), partially positive for ubiquitin (Fig. 1F), Cell Penetrating Peptide partially positive for SOD1 (Fig. 1G), negative for TDP-43, p-TDP-43 and GSK126 chemical structure FUS. The eosinophilic core of LBHIs

was positive for ubiquitin (Fig. 1J) and SOD1 (Fig. 1K) and negative for p-NFP (Fig. 1I). Because the LBHIs were very few, we could not confirm the reactivity of the round inclusions with antibodies against TDP43, p-TDP-43 and FUS. Neither skein-like inclusions nor round hyaline inclusions were identified by p-TDP-43, and no basophilic inclusions were identified by FUS protein. Indeed, it is not always determinable to exclude TDP-43 or FUS pathologies. A number of p-tau protein-positive globose NFTs and threads were observed in the periaqueductal gray matter, oculomotor nuclei, and trochlear nuclei (Fig. 1L,M) and these structures were also positive for both 3-repeat tau and 4-repeat tau (Fig. 1N,O). The tangles were also positive by both Bielschowsky’s silver staining and Gallyas-Braak staining (Fig. 1P). Although this case was initially clinically diagnosed as having sporadic ALS, the neuropathological findings showed features of FALS with a SOD1 mutation. DNA analysis of frozen-brain tissue revealed the presence of the I113T SOD1 mutation (Fig. 2). I113T is one of the most common mutations of the SOD1 gene.[1] Phenotypic expression of this mutation is variable in clinical manifestations, including age of onset and disease prognosis.

This illustrates further that PID are not diseases affecting children only and that the Selleck Barasertib awareness for adult presentations of these diseases is increasing. In

some of our contributing centres, adults are treated in paediatrics departments because there is no expertise in internal medicine departments. This is an issue that certainly still needs to be given more attention from policy makers, and our observations should help to bring this issue on the agenda. The genetic basis of their disease remains undefined for a large number of patients, especially for those with antibody deficiencies. The gender distribution shows that males were affected much more frequently by PID than females. Interestingly, in patients younger than 30 years, boys are

affected more frequently even if X-linked diseases HDAC inhibitor are excluded. A specific example for this was recently given in autoimmune lymphoproliferative syndrome (ALPS) [20]. The reason for this is unknown, but may reflect additional genetic susceptibility factors encoded on the Y-chromosome. We further observed that among patients older than 30 years, more women than men are affected by a PID. We have no explanation for this. Another important issue is the diagnostic delay which is a marker for the improvement of awareness of PID. This is especially true in PID that present less severely and may go undiagnosed for many years, such as CVID. We were able to identify positive overall trends towards a shorter diagnosis for agammaglobulinaemias and IgG subclass deficiency. Conversely, CVID in particular continues to present with a very high median diagnostic delay of 3 years in many patients who receive Carbachol their diagnosis more than 10 or even 20 years after disease onset. The documentation progress of the ESID database has made it the largest single collection of PID patient data to date. The more countries manage to organize a complete coverage

of PID documentation on the national level, the better we can judge the meaning of numbers produced by the ESID database. In a survey among the database users conducted from July to September 2010, we tried to determine how the system could be made more user-friendly in order to increase reporting. Major issues we identified were slow loading of the web pages and the complicated structure of the system, with more than 210 disease entities. We addressed these issues by upgrading to new hardware and restructuring the data entry system, which led to a reduction to 138 entities. Conversely, we also realized that our current core data set is obviously too complex and unfocused, because for many patients large parts remain undocumented. Therefore, we decided to define a new, more focused core data set which will be discussed by representatives of all national registries in Freiburg in December 2011.

On the other hand, earlier restoration of renal function may mitigate cardiovascular risks associated with uremia, potentially preventing significant cardiovascular morbidity and mortality. Observational studies seemed to suggest that earlier transplantation does not appear to be associated with better patient and graft survival. A retrospective review of 19,471 first-time preemptive renal transplant recipients reported to the UNOS data7 between January 1, 1995 and December 31, 2009, showed that annual mean estimated GFR (eGFR) at the time of pre-emptive transplant ranged

from 9.2 ml/min/1.73 m2 to 13.8 ml/min/1.73 m2. Nonetheless, the authors did not detect any statistically significant differences in patient or death-censored graft survival between strata of eGFR at the time of transplant. It is noteworthy that to find more date, there is no randomized controlled trial available, from which to draw substantive conclusions on the optimal timing for renal transplantation prior to the initiation of dialysis therapy. While most preemptive renal transplants are from a living donor, up to a quarter of these transplants occur with deceased donors. Therefore, it also raise to question the timing for listing these patients, balancing the chances of receiving a deceased donor kidney prior to dialysis initiation and optimizing resources in maintaining these potential

recipients on the list. Analysis of the Scientific selleck chemicals Registry of Transplant Recipients database of PRKACG 57,677 renal transplant candidates8 demonstrated that a higher renal function at listing was strongly associated with a greater likelihood of receiving a preemptive transplant and a significantly better survival advantage. Mean eGFR at listing was 14.8 ml/min/1.73 m2 and the adjusted odds ratio for preemptive transplant was 1.45 per 5 ml/min/1.73 m2 increase in eGFR. Unfortunately, available literature is again mainly observational

and retrospective in nature. In summary, preemptive renal transplantation appears to confer superior allograft and patient survival benefit, reasons for which are multifactorial and mainly related to patient selection, correction of the uremic milieu and even unknown factors peculiar to the procedure itself. Outcomes of the transplant did not seem to differ when stratified by the eGFR at the time of transplant, but placing these patients on the waitlist early increases their odds of having the transplant performed preemptively. 1. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341:1725–1730. 2. Meier-Kriesche HU, Port FK, Ojo AO et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000; 58:1311–1317. 3.

albicans cells after PMN’s candidacidal activity induced by sera after primary sc booster injection of M5-BSA conjugate remains the same as for sera with non-inactivated complement, although statistically not significantly higher in comparison with percentage of PI+ C. albicans cells after PMN’s candidacidal activity induced by complement-inactivated control sera. PMN’s candidacidal activity induced by complement-inactivated M6-BSA conjugate immune sera

decreased in comparison with complement non-inactivated sera. Candidacidal activity of PMN induced by complement-inactivated M6-BSA conjugate immune sera stays statistically significantly higher than inactivated control sera for sera after secondary sc booster injection of M6-BSA conjugate (Fig. 6).

PMN’s candidacidal activity assay demonstrated difference between M5-BSA see more and M6-BSA conjugates ability to induce production of antibodies improving killing action of PMN and reveal significant impact of active complement on C. albicans Nivolumab price cells opsonization for PMN’s candidacidal activity. In the last few decades, the incidence of invasive candidiasis significantly increased [22-24]. This increase in Candida infection is associated with the increasing numbers of patients susceptible for the development of fungal infections, including patients undergoing major surgery (especially gastrointestinal surgery), blood and marrow transplantation and solid organ transplantation; patients with AIDS, neoplastic disease and advanced age; and patients receiving immunosuppressive therapy [22-25]. Our previously published results revealed the ability of linear α-1,2-linked mannooligomers conjugates to induce antibodies elevating

candidacidal activity of leucocytes [13, 14]. The results presented here are a continuation of the immunomodulatory properties assessment of α-mannoside BSA-based glycoconjugates. For this study, two synthetically prepared oligomannosides (pentamannoside: M5 and hexamannoside: M6) with α-1,6-linked branching unit in addition to α-1,2-, α-1,3-linked mannose residues (Fig. 1) were used for preparation of BSA-based conjugates and for subsequent immunization. We analysed the ability of immunization-induced antibodies to react with purified acid -stable mannan Cediranib (AZD2171) moiety and with natural form of mannan as a cell wall component of intact yeast and hyphal cells. Comparison of mannan-specific antibodies levels induced by M5-BSA conjugate and M6-BSA conjugate revealed higher immunogenicity of M6-BSA conjugate (Fig. 2). M6-BSA conjugate mannooligomers, in contrast to M5-BSA conjugate mannooligomers, possess additional α-linked mannosyl unit at non-reducing end of oligomers. Markedly more beneficial immunomodulatory effect of M6-BSA conjugate resulted also from induction of immunoglobulin isotype class switch from IgM to IgG after secondary sc booster injection, clearly detected for mannan C. albicans serotype A (Fig. 2).

Moreover, purified DNA was able to activate a TLR9- and IRF1-dependent pathway leading to IL-12p70 induction. In summary, our data suggest that TLR7 and TLR9 collaborate in a fungal recognition mechanism that targets nucleic acids (RNA and DNA, respectively) and activates a common, MyD88- and IRF1-dependent,

pathway. Activation of this pathway was absolutely dependent on phagocytosis and phagosomal acidification, both of which are known requirements for TLR9- and TLR7-mediated recognition. An additional feature of the TLR7/9-dependent responses described here is their cell-type specificity. Indeed, BMDC, but not BMDM, mounted robust cytokine responses to yeast nucleic acids. The reasons for these differences are presently unclear, but they may relate to differential

Paclitaxel manufacturer TLR or IRF1 expression or to differential STAT1 phosphorylation in response to nucleic acid stimulation [51]. Our data are only apparently in contrast with previous reports indicating that TLR9-defective mice display similar [28, 38] or even increased [14] resistance to C. albicans. Differences between our data and those of others were unequivocally linked, in the present study, to the different doses used for challenge. In fact, increased susceptibility PLX4032 order to C. albicans infection in the absence of TLR7 or TLR9 was observed only using a low challenge dose. When we challenged mice with the high doses used in the studies cited above, no effect of TLR7 or TLR9 deficiency was observed. Our data are in agreement with the notion that lack of specific host factors has different and even opposite effects on the outcome of experimental infection depending on the challenge dose, the associated

severity of infection, and risk of death [19, 52, 53]. Thus, it appears that the Rutecarpine contribution of TLR7 or TLR9 to host defenses against C. albicans can be evidenced only under experimental conditions associated with mild, sublethal infection. The use of low rather than high challenge doses seems logical, since under most natural circumstances, the immune system is exposed to low numbers of microbial cells in the initial stages of infection. Moreover, overwhelming infection is often associated with the deleterious release of pathophysiological mediators by the host and/or of immunosuppressive products by the pathogen, both of which may obscure the contribution of individual immune factors [19, 52-54]. Collectively, our data indicate the presence of at least two different cellular mechanisms underlying fungal recognition that lead to the production of two different sets of defense factors. The first mechanism, underlying the production of IL-23 and TNF-α, relies predominantly on the detection of cell-wall structures by receptors located on the host cell surface, such as dectin-1. This mechanism does not necessarily require phagocytosis and is largely independent from TLR or TRL adaptors.

We explore the lingering questions regarding pericyte phenotypic identity and lineage. The expression of different pericyte markers (e.g., SMA, Desmin, NG2, and PDGFR-β) varies for different subpopulations and tissues. Previous use of these markers to identify pericytes has suggested potential phenotypic overlaps and plasticity toward other

cell phenotypes. Our review chronicles the state of the literature, identifies critical unanswered questions, and motivates future research aimed at understanding this intriguing cell type and harnessing its therapeutic potential. “
“This chapter TGF-beta inhibitor contains sections titled: Introduction What Are Speckles? Basic Properties Significance of Speckles in LDPI Further Analysis of the Consequence of Speckle in LDPI Consequences and Concluding Remarks References “
“Hypoxia-inducible factor is a hypoxia-responsive transcriptional factor that controls the expression of proteins contributing to homeostatic responses to hypoxia. Spatial heterogeneity of tissue oxygenation

has been postulated as a determinant of structure and function of hepatic lobules, although its molecular mechanisms remain unknown. This study aimed to examine the role of HIF-1 expressed in hepatocytes in regulation of hepatic microcirculation. We have generated mice harboring a floxed HIF-1α allele, and employed the albumin-Cre transgenic line to inactivate the gene site-specifically in hepatocytes. Intravital observation CP868596 of the hepatic microcirculation revealed extension of hepatic lobules in HIF-1α-deficient mice. Measurement of microvascular diameter, velocity, and local oxygen tension by laser-assisted phosphorimetry showed that the oxygen consumption in the lobules of HIF-1α-deficient mice was greater than that in those of control mice. Isolated hepatocytes from HIF-1α-deficient mice also stimulated oxygen consumptions with increased contents of mtDNA.

Overexpression of HIF-1α decreased the expression of PGC-1α mRNA, whereas the knockdown of the HIF-1α gene increased it, suggesting that HIF-1 regulates cellular respiration through mitochondrial biogenesis. Our results suggest that constitutive expression of HIF-1α in hepatocytes acts as a determinant of hepatic http://www.selleck.co.jp/products/Pomalidomide(CC-4047).html lobular structure and oxygen consumption by changing mitochondrial contents. “
“NADPH oxidase activation results in ROS overproduction that is the pathological basis of I/R injury. This study aimed to investigate potential effects of ORG on I/R-induced ROS production in rat mesenteric microvasculature and underlying mechanisms. Mesenteric I/R in Male Wistar rats (200~250 g) was induced by ligation of the mesenteric artery and vein for 10 minutes followed by reperfusion for 60 minutes by releasing of the occlusion. The rats were infused intravenously with or without ORG (5 mg/kg per hour) 10 minutes before ischemia (pretreatment) or 20 minutes after reperfusion (posttreatment).

Pair wise comparisons were carried out by Dunn’s method

to account for unequal group sizes. A two-way anova was performed to assess differences between the EX 527 manufacturer routes of challenge regarding MMCP-1, while Fisher exact tests were used to address this regarding anaphylaxis. Results were pooled for subsequent analyses when no differences between i.p. and p.o. challenge or interactions could be found. In the lupin model, close to 70% of sensitized mice challenged with lupin developed reactions with a score of 2 or higher (Table 2). Challenged with peanut, soy or fenugreek 37.5%, 31.5% and 12.5% of the lupin-sensitized mice developed serious anaphylaxis (score 2 or higher), respectively. Twenty-five percent of the fenugreek challenged mice Panobinostat purchase did not react, while

all sensitized mice challenged with peanut or soy showed at least a weak reaction with increased itching. All sensitized groups showed significantly higher anaphylactic score compared to control groups (P < 0.001), and the lupin challenged mice showed significantly stronger reactions than mice challenged with soy (P = 0.004), peanut (P = 0.01) and fenugreek (P < 0.001) (Fig. 1A). I.p. challenge with lupin resulted in more serious reactions than p.o. challenge with lupin, but no differences could be seen regarding route of challenge (i.p. versus p.o.) for the cross-allergens (peanut, soy and fenugreek). In the fenugreek model, all sensitized mice challenged with fenugreek developed serious anaphylactic reactions of score 2 or higher (Table 2). Mice challenged with fenugreek i.p. developed more serious reactions than mice challenged with fenugreek p.o. Challenged with peanut or soy about 30% of the fenugreek-sensitized mice developed serious reactions, while 75% of lupin challenged mice reacted with a score of 2 or more. Peanut and soy challenges did not result ID-8 in any clinical reaction in 37.5% and 31.25% of the mice, respectively, while all

mice except one reacted to lupin. All sensitized groups showed significantly higher anaphylactic score than control groups (P < 0.001 for fenugreek, i.p. and p.o., and lupin; P = 0.02 for soy and peanut), and the fenugreek challenged mice showed significantly stronger reactions than mice challenged with lupin, soy or peanut (P ≤ 0.001) (Fig. 1C). MMCP-1 was measured as a reflection on the local anaphylactic reaction in the gut, as it is released from mast cells upon activation. Sensitized mice challenged i.p. with the primary antigen responded with a MMCP-1 level much higher than all other groups in both models, including mice challenged p.o. with the primary allergen (Fig. 1B,D). In contrast, mice challenged p.o. with lupin in the lupin model (Fig. 1B) had higher MMCP-1 levels than the other groups, while mice challenged (both p.o. and i.p.) with peanut, soy or fenugreek as well as only immunized mice (not challenged) all had significantly higher levels than control mice.